All patients admitted into the study had to receive the target dose of captopril (75 mg/day) 3 days after admission. In addition, only patients aged ≥65 years were recruited. The study protocol ...

Objective: To verify the feasibility, tolerability and efficacy of the combination of captopril (75 mg/day) and candesartan (8 mg/day) in early postinfarction phases of not thrombolysed and ...

The 70s was also a decade of success for Squibb, when its researchers Miguel Ondetti and David Cushman created Capoten (captopril), which was the first in a new class of high blood pressure agents ...